
|Articles|September 8, 2016
Key Stakeholders Needed in the Development of Outpatient Naloxone Policies
Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses key stakeholders involved in developing and implementing outpatient naloxone policies.
Advertisement
Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses key stakeholders involved in developing and implementing outpatient naloxone policies.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
MRD, ctDNA Testing May Help Diagnose Multiple Myeloma Precursor Conditions
2
ACIP Votes to End Universal Hepatitis B Vaccination Recommendation for Infants
3
Longevity Medicine: Just Another Reincarnation of Diet and Exercise or Something Altogether Different?
4
Low-Dose Cannabinoids Show Potential to Restore Serotonin Levels and Reduce Inflammation in HIV, Study Finds
5


















































































































































































































